1. Home
  2. PMVP vs IHD Comparison

PMVP vs IHD Comparison

Compare PMVP & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • IHD
  • Stock Information
  • Founded
  • PMVP 2013
  • IHD 2011
  • Country
  • PMVP United States
  • IHD United States
  • Employees
  • PMVP N/A
  • IHD N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • IHD Investment Managers
  • Sector
  • PMVP Health Care
  • IHD Finance
  • Exchange
  • PMVP Nasdaq
  • IHD Nasdaq
  • Market Cap
  • PMVP 85.5M
  • IHD 89.7M
  • IPO Year
  • PMVP 2020
  • IHD N/A
  • Fundamental
  • Price
  • PMVP $1.42
  • IHD $5.19
  • Analyst Decision
  • PMVP Strong Buy
  • IHD
  • Analyst Count
  • PMVP 3
  • IHD 0
  • Target Price
  • PMVP $5.33
  • IHD N/A
  • AVG Volume (30 Days)
  • PMVP 161.2K
  • IHD 27.7K
  • Earning Date
  • PMVP 02-27-2025
  • IHD 01-01-0001
  • Dividend Yield
  • PMVP N/A
  • IHD 10.32%
  • EPS Growth
  • PMVP N/A
  • IHD N/A
  • EPS
  • PMVP N/A
  • IHD N/A
  • Revenue
  • PMVP N/A
  • IHD N/A
  • Revenue This Year
  • PMVP N/A
  • IHD N/A
  • Revenue Next Year
  • PMVP N/A
  • IHD N/A
  • P/E Ratio
  • PMVP N/A
  • IHD N/A
  • Revenue Growth
  • PMVP N/A
  • IHD N/A
  • 52 Week Low
  • PMVP $1.32
  • IHD $4.49
  • 52 Week High
  • PMVP $2.26
  • IHD $5.47
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 43.76
  • IHD 56.04
  • Support Level
  • PMVP $1.40
  • IHD $5.11
  • Resistance Level
  • PMVP $1.46
  • IHD $5.25
  • Average True Range (ATR)
  • PMVP 0.05
  • IHD 0.06
  • MACD
  • PMVP 0.01
  • IHD 0.01
  • Stochastic Oscillator
  • PMVP 58.29
  • IHD 79.17

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

Share on Social Networks: